ARCHIVES

RFAs available: Chemoprevention Clinical Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

Weinstein Applauds Investigation Report

September 26, 1997

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012